Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

L-Serine Dehydratase

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on L-Serine Dehydratase:

Pubmed Logo
Occurrence of D-serine in rice and characterization of rice serine racemase.
Germinated, unpolished rice was found to contain a substantial amount of...
10th June, 2009
Department of Life Science and Biotechnology, Faculty of Chemistry, Phytochemistry. 2009 Feb;70(3):380-7. Epub 2009 Feb 25.
DOI Direct Link
Adaptational modification of serine and threonine metabolism in the liver to essential amino acid deficiency in rats.
It is known that plasma serine and threonine concentrations are elevated...
15th May, 2009
Research Institute for Health Fundamentals, Ajinomoto Co., Inc., Kawasaki, Amino Acids. 2009 Mar;36(3):555-62. Epub 2008 Jun 27.
DOI Direct Link
A quantum mechanical/molecular mechanical study on the catalysis of the pyridoxal 5'-phosphate-dependent enzyme L-serine dehydratase.
The catalytic mechanism of a pyridoxal 5'-phosphate-dependent enzyme,...
7th January, 2009
School of Life Sciences, and Hefei National Laboratory for Physical J Phys Chem B. 2008 Oct 16;112(41):13091-100. Epub 2008 Sep 24.
DOI Direct Link
Dispersed mutations in histone H3 that affect transcriptional repression and chromatin structure of the CHA1 promoter in Saccharomyces cerevisiae.
The histone H3 amino terminus, but not that of H4, is required to prevent...
13th November, 2008
Department of Biomedical Sciences, State University of New York at Albany Eukaryot Cell. 2008 Oct;7(10):1649-60. Epub 2008 Jul 25.
DOI Direct Link
Deficiency in l-serine deaminase results in abnormal growth and cell division of Escherichia coli K-12.
The loss of the ability to deaminate l-serine severely impairs growth and...
25th September, 2008
Biology Department, Concordia University, 1455 de Maisonneuve Ave, Mol Microbiol. 2008 Aug;69(4):870-81. Epub 2008 Jun 4.
DOI Direct Link

View more research publications.

Press Releases About L-Serine Dehydratase:

BioPortfolio Logo
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting 1st November, 2009 Schering-Plough Corporation
BOSTON, Nov. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported two data presentations supporting response guided therapy with boceprevir combination therapy in
Cylene to Announce New Data on Its First-in-Class Oral CK2 Inhibitor Against Cancer at BIO Conference 19th May, 2009 Cylene Pharmaceuticals, Inc.
SAN DIEGO, May 19 /PRNewswire/ -- Cylene Pharmaceuticals, Inc., announced today that it will present major advances in the development of their first-in-class, CK2 inhibitor CX-4945 at the 2009 BIO
Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 23rd April, 2009 Schering-Plough Corporation
48-week investigational regimen yielded nearly double SVR rate compared to standard of care Update on next-generation HCV protease inhibitor SCH 900518 presented at EASL annual meeting COPENHAGEN,
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 24th November, 2008 Schering-Plough Corporation
Company reaffirms its innovation leadership and long-term commitment to hepatitis research KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today provided a
Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 1st November, 2008 Schering-Plough Corporation
Interim results of HCV SPRINT-1 study presented at AASLD annual meeting Pivotal Phase III studies ongoing in treatment naive patients and those who failed prior treatment SAN FRANCISCO, Nov. 1

BioNews Results for L-Serine Dehydratase:

RSS Logo
BioPortfolio Logo
Enzyme Research: Scientists at RIKEN detail research in enzyme research
NewsRX:  Nov 9 2009 5:55AM Matching: l serine

L-Serine Dehydratase Patents:

USPTO Logo
US Patent No.Title
7611720 Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
7033790 Proteins and nucleic acids encoding same
7018829 Metabolically engineered microbial cell with an altered metabolite production
7018794 Methods for monitoring multiple gene expression
6908740 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for L-Serine Dehydratase scientists - we have details of around 56 individuals working on L-Serine Dehydratase .


This page has been viewed 348 times
Recent Search Terms used to find this page: serine dehydratase | serine dehydratase | serine dehydratase | dehydratase mechanism | serine dehydratase | L-serine dehydratase | dehydratase mechanism | serine dehydratase mechanism | serine dehydratase mechanism | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for L-Serine Dehydratase across BioPortfolio, or for L-Serine Dehydratase Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.